Latest Content

From gut-focused longevity to bitterness blocking, dsm-firmenich’s Julia Duchastel and Kathleen McNamara share what’s new at SupplySide Global and what’s ahead for 2027.

At SupplySide Global 2026, a certifier of wild-harvested ingredients and an organic ingredient supplier discussed drought, yield loss, and partnership models for resilient sourcing.

At SupplySide Global, Gelita’s Angie Rimel explains how collagen proteins can help brands build nutrient-dense products that earn repeat purchases.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Denis Neville, founder and CEO of CoreFX Ingredients, about the launch of CreaSHLD-IN.

At SupplySide Global, Kriti Chaudhary explains how nutraceutical brands can turn clinical research into a price premium and a claim that holds up.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Brian Appell, product manager, Givaudan, about the launch of NovaBerin for the metabolic health market.

Researchers analyzing FDA adverse-event data report higher cardiac event reporting for caffeine and stimulant products, while the Council for Responsible Nutrition says the design cannot show risk.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Elzaphan Hotam, director at TriNutra, about new clinical and preprint data on ThymoQuin.

At SupplySide Global, Dominik Mattern discussed Balchem’s Optifolin+, methylation and DNA health, formulation challenges, and Vital Choline’s cognitive-health research amid growing interest in longevity and healthy aging.

The organic excipient is positioned to combine lubrication, flow, and compression support in a single addition.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Brian Metzger, vp of business development and sales at Prosur Inc., about how the Make America Healthy Again movement is accelerating clean-label reformulation.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Lixin Ding, chief scientific officer at BGG, about a new watermelon-tamarind-cayenne beverage concept built around ApplePhenon.

At SupplySide Global, Ishani Maharaj explains how Ingredients + Specialties from Univar Solutions helps brands address nutrition trends—from GLP-1-friendly formats to multifunctional products—using formulation expertise and labs to accelerate product development.

Regulators in both countries are asking for documentation that shows how an ingredient was made, not just what it is called.

At SupplySide Global 2026, 5 speakers from ingredient suppliers discussed protein, fiber, botanicals, and peptides for consumers using or leaving GLP-1 medications.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.

The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.

Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.

Session speakers at SupplySide Global 2026 covered consumer survey data, extraction methods, dosing, and claims for formulators working with functional mushrooms in beverages and foods.

Panelists at SupplySide Global 2026 discussed protein's limits, shifting supplement formats, clean-label expectations, and plainer ingredient communication.

Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.

Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Mit Metah, executive vice president at Unibar, about the launch of ElaQuin and how it connects to Bellaneo, Unibar’s melanin-inhibiting cosmeceutical ingredient.

At SupplySide Global 2026, Jordi Riera of Kaneka Probiotics describes the company’s focus on research and probiotics for women’s health.

A roundup of recent adaptogen trials, newer botanical and fermentation-derived ingredients, and approvals in Canada and South Korea, with a look at the limits of the evidence for manufacturers.

From skin and coat to oral health, a roundup of recent pet supplement research, regulatory signals, and product developments.

AHPA, CHPA, CRN, and UNPA say placing ODS under the Office of Nutrition Research would add a layer of bureaucracy. NIH is accepting comments through October 28.

From canine arthritis to the microbiome, and from the proposed Animal Health Supplement Act to owners’ views on longevity, here is what has been developing for companion animal products.

Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.

Clinical research moves beyond compliance, focusing on smarter trial design, risk-based quality, and “evidence engineering” to deliver decisive, decision-ready results.

The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.

AuraFen, BILVORA, and IMBE debut at SupplySide Global 2026, and the company will also highlight its CaFi digestive health ingredient.